Fundz

Schneider Electric to acquire PTC for $22.6B

PRIVATEOct 05, 2026

Acquiring Company

Schneider Electric

Acquired Company

PTC Therapeutics

ParisSouth PlainfieldManufacturingEnergymachineryBiotechnology

Description

Schneider Electric plans to acquire PTC in an all-cash transaction valued at approximately $22.6 billion. This acquisition will enhance Schneider's portfolio in industrial software by integrating PTC's advanced CAD and lifecycle management technologies. The deal is expected to close by Q3 2027, pending necessary approvals. The merger aims to improve the digital connectivity between engineering and operational data.

Company Information

Company

Schneider Electric

Location

35 Rue Joseph Monier

Paris, Ile-de-France, France

About

Schneider Electric is a multinational corporation specializing in energy management and automation solutions. The company provides integrated solutions across multiple market segments, including utilities, infrastructure, and industrial applications. With a strong commitment to sustainability, Schneider Electric aims to provide innovative products and services that enhance efficiency and productivity. It operates globally, serving a diverse range of industries and customers.

Fundz sees it the moment Schneider Electric makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Olivier
Likely contact at this company
••••••••@••••••••

See Olivier's verified email →

Gwenaelle
Senior decision-maker at this company
••••••••@••••••••

See Gwenaelle's verified email →

Preeti
Senior decision-maker at this company
••••••••@••••••••

See Preeti's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Schneider Electric's next move

Learn about Strategic plan

Frequently asked

Who acquired PTC Therapeutics?

PTC Therapeutics was acquired by Schneider Electric, based in Paris. The deal was reported on October 5, 2026. Schneider Electric is a multinational corporation specializing in energy management and automation solutions. Schneider Electric is privately held and operates in Manufacturing.

When did Schneider Electric acquire PTC Therapeutics?

Schneider Electric's acquisition of PTC Therapeutics was reported on October 5, 2026. Schneider Electric plans to acquire PTC in an all-cash transaction valued at approximately $22.6 billion. This acquisition will enhance Schneider's portfolio in industrial software by integrating PTC's advanced CAD and lifecycle management technologies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does PTC Therapeutics do?

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. It is publicly traded (PTCT), operating in Biotechnology, and is based in South Plainfield.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.